Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dexcom Eyes US FDA Clearance For 15-Day CGM, But Insurance Coverage Remains Uncertain
Upgrade could boost Dexcom’s competitive positioning against Abbott’s Libre 3 Plus.
12 Mar 2025
•
By
Shubham Singh
The new device is expected to enhance patient experience by extending wear time beyond its current 10-day G7 sensor.
More from Business
More from Policy & Regulation